Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Non-alcoholic Fatty Liver Disease"" wg kryterium: Temat


Tytuł:
Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort.
Autorzy:
Park H; Department of Family Medicine, Myoungji Hospital, Hanyang University College of Medicine, Goyang, Korea.
Yoon EL; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
Chung GE; Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Choe EK; Department of Surgery, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Bae JH; Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Choi SH; Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Kim M; Department of Radiology, Hanyang University College of Medicine, Seoul, Korea.
Hwang W; Hanyang Institute of Bioscience and Biotechnology, Department of Pre-Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Kim HL; College of Pharmacy, Sahmyook University, Seoul, Korea.
Yang SY; Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Jun DW; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.; Hanyang Institute of Bioscience and Biotechnology, Department of Pre-Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2024 Mar 15; Vol. 18 (2), pp. 316-327. Date of Electronic Publication: 2023 Aug 10.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/genetics
Non-alcoholic Fatty Liver Disease*/complications
Humans ; Retrospective Studies ; Cross-Sectional Studies ; Risk Factors ; Republic of Korea/epidemiology ; Polymorphism, Single Nucleotide ; Genetic Predisposition to Disease ; Liver/pathology ; Genotype
Czasopismo naukowe
Tytuł:
Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults.
Autorzy:
Zeng F; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, No.601 Huangpu Road West, Guangzhou, 510632, China. .; Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-Sen University, Guangzhou, 510275, China. .
Su X; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, No.601 Huangpu Road West, Guangzhou, 510632, China.
Liang X; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, School of Medicine and School of Life Sciences, Westlake University, Hangzhou, 310030, China.
Liao M; Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.
Zhong H; Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-Sen University, Guangzhou, 510275, China.
Xu J; Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-Sen University, Guangzhou, 510275, China.
Gou W; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, School of Medicine and School of Life Sciences, Westlake University, Hangzhou, 310030, China.
Zhang X; Big Data Decision Institute, Jinan University, No.601 Huangpu Road West, Guangzhou, 510632, China.
Shen L; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, School of Medicine and School of Life Sciences, Westlake University, Hangzhou, 310030, China.
Zheng JS; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, School of Medicine and School of Life Sciences, Westlake University, Hangzhou, 310030, China. .
Chen YM; Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-Sen University, Guangzhou, 510275, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 07; Vol. 22 (1), pp. 104. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/metabolism
Gastrointestinal Microbiome*
Microbiota*
Middle Aged ; Humans ; Animals ; Mice ; Aged ; Liver/metabolism ; Independent Living
Czasopismo naukowe
Tytuł:
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles.
Autorzy:
Nachit M; Laboratory of Hepato-Gastroenterology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium. .; Department of Imaging and Pathology, KU Leuven, Louvain, Belgium. .
Dioguardi Burgio M; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.; Department of Radiology, Beaujon University Hospital Paris Nord, AP-HP, Clichy, France.
Abyzov A; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.
Garteiser P; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.
Paradis V; Team 'From Inflammation to Cancer in Digestive Disease', Center of Research on Inflammation, Université Paris Cité, Inserm, Paris, France.; Department of Pathology, Beaujon University Hospital Paris Nord, AP-HP, Clichy, France.
Vilgrain V; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.; Department of Radiology, Beaujon University Hospital Paris Nord, AP-HP, Clichy, France.
Leclercq I; Laboratory of Hepato-Gastroenterology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium.
Van Beers BE; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.; Department of Radiology, Beaujon University Hospital Paris Nord, AP-HP, Clichy, France.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Mar; Vol. 34 (3), pp. 1461-1470. Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/pathology
Carcinoma, Hepatocellular*/complications
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/complications
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/pathology
Humans ; Cross-Sectional Studies ; Liver/pathology ; Liver Cirrhosis/pathology ; Muscle, Skeletal/diagnostic imaging ; Muscle, Skeletal/pathology
Czasopismo naukowe
Tytuł:
Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease.
Autorzy:
Hooshmand Gharabagh L; Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Imam Khomeini Hospital, Urmia, Iran. Electronic address: .
Shargh A; Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
Mohammad Hosseini Azar MR; Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Imam Khomeini Hospital, Urmia, Iran.
Esmaeili A; Department of Clinical Pharmacy, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran; Experimentaland Applied Pharmaceutical Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: .
Pokaż więcej
Źródło:
Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2024 Mar; Vol. 48 (3), pp. 102279. Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Metformin*/therapeutic use
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/drug therapy
Benzhydryl Compounds*
Glucosides*
Humans ; Pioglitazone/therapeutic use ; Hypoglycemic Agents/therapeutic use ; Prospective Studies ; Lipids
Czasopismo naukowe
Tytuł:
Association of five diet scores with severe NAFLD incidence: A prospective study from UK Biobank.
Autorzy:
Petermann-Rocha F; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Centro de Investigación Biomédica, Facultad de Medicina, Universidad Diego Portales, Santiago, Chile.
Carrasco-Marin F; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Centro de Vida Saludable, Universidad de Concepción, Concepción, Chile.
Boonpor J; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Faculty of Public Health, Kasetsart University, Chalermphrakiat Sakon Nakhon Province Campus, Kasetsart University, Sakon Nakhon, Thailand.
Parra-Soto S; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Department of Nutrition and Public Health, Universidad del Bío-Bío, Chillán, Chile.
Shannon O; Human Nutrition & Exercise Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Malcomson F; Human Nutrition & Exercise Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Phillips N; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Jain M; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Deo S; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.; Surgical Services, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA.; Case School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Livingstone KM; Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia.
Dingle SE; Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia.
Mathers JC; Human Nutrition & Exercise Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Forrest E; Department of Gastroenterology, Glasgow Royal Infirmary, University of Glasgow, Glasgow, UK.
Ho FK; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Pell JP; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Celis-Morales C; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Human Performance Laboratory, Education, Physical Activity and Health Research Unit, Universidad Católica del Maule, Talca, Chile.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Mar; Vol. 26 (3), pp. 860-870. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/etiology
Diet, Mediterranean*
Humans ; Prospective Studies ; Risk Factors ; Biological Specimen Banks ; UK Biobank ; Diet/adverse effects
Czasopismo naukowe
Tytuł:
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study.
Autorzy:
Krishnan A; Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. .; Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Department of Medicine, Section of Gastroenterology and Hepatology, West Virginia University School of Medicine, Morgantown, WV, USA. .
Schneider CV; Department of Medicine III, Gastroenterology, Metabolic Diseases, and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
Hadi Y; Department of Medicine, Section of Gastroenterology and Hepatology, West Virginia University School of Medicine, Morgantown, WV, USA.
Mukherjee D; Department of Medicine, Apex Institute of Medical Science, Kolkata, West Bengal, India.
AlShehri B; Diabetes and Endocrinology, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
Alqahtani SA; Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Liver Transplant Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
Diabetologia [Diabetologia] 2024 Mar; Vol. 67 (3), pp. 483-493. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/epidemiology
Non-alcoholic Fatty Liver Disease*/drug therapy
Non-alcoholic Fatty Liver Disease*/complications
Cardiovascular Diseases*
Heart Failure*/complications
Humans ; Young Adult ; Adult ; Hypoglycemic Agents/therapeutic use ; Glucagon-Like Peptide-1 Receptor Agonists ; Glucose ; Retrospective Studies ; Cohort Studies ; Treatment Outcome ; Glucagon-Like Peptide-1 Receptor/agonists
Czasopismo naukowe
Tytuł:
Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality.
Autorzy:
Han H; Department of Health, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Yu Q; Department of Internal Medicine, The People's Hospital of Huaiyin, Jinan 250021, China.
Qin N; Department of Nutrition, Qilu Hospital of Shandong University, Jinan, China.
Song B; Department of Out-patient, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Meng Y; Department of Nutrition, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Feng Z; Department of Nutrition, Qilu Hospital of Shandong University, Jinan, China.
Li Z; Department of Nutrition, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Chen L; Department of Health, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; Department of Nutrition, Qilu Hospital of Shandong University, Jinan, China. Electronic address: .
Pokaż więcej
Źródło:
Annals of hepatology [Ann Hepatol] 2024 Mar-Apr; Vol. 29 (2), pp. 101177. Date of Electronic Publication: 2023 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Humans ; Male ; United States/epidemiology ; Female ; Nutrition Surveys ; Liver Function Tests ; Linear Models ; Bilirubin
Czasopismo naukowe
Tytuł:
Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study.
Autorzy:
Zhang Z; Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Li M; Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Ji G; Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhang L; Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2024 Mar; Vol. 54 (3), pp. e14116. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/genetics
Sleep Apnea Syndromes*/epidemiology
Sleep Apnea Syndromes*/genetics
Humans ; Mendelian Randomization Analysis ; Body Mass Index ; Causality ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLD.
Autorzy:
Kim GA; Department of Internal Medicine, College of Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea.
Park Y; Department of Internal Medicine, College of Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea.
Oh SJ; Department of Internal Medicine, College of Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea.
Jung J; Department of Biostatistics, Korea University, Seoul, Republic of Korea.
Han S; Department of Biostatistics, Korea University, Seoul, Republic of Korea.
Chang HS; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Park SW; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim TH; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Park HW; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Choe J; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim J; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee HC; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Mar; Vol. 44 (3), pp. 738-748. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/etiology
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/pathology
Liver Neoplasms*/diagnosis
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Humans ; Retrospective Studies ; Liver Cirrhosis/complications ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/epidemiology ; Risk Factors ; Fibrosis
Czasopismo naukowe
Tytuł:
Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients.
Autorzy:
Wang M; The Second Clinical Medical College, Jinan University, Guangzhou, China.
Tang S; The Second Clinical Medical College, Jinan University, Guangzhou, China.
Li G; The Second Clinical Medical College, Jinan University, Guangzhou, China.
Huang Z; The Second Clinical Medical College, Jinan University, Guangzhou, China.
Mo S; The Second Clinical Medical College, Jinan University, Guangzhou, China.
Yang K; Department of Ultrasound, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China.
Chen J; Department of Ultrasound, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China.
Du B; Department of Ultrasound, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China.
Xu J; Department of Ultrasound, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China. .
Ding Z; Department of Ultrasound, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China. .
Dong F; Department of Ultrasound, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Feb 23; Vol. 24 (1), pp. 81. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Elasticity Imaging Techniques*
Humans ; Biopsy ; ROC Curve ; Liver/diagnostic imaging
Czasopismo naukowe
Tytuł:
Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study.
Autorzy:
Yu C; Jiangxi Medical College, Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China.; Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.; Jiangxi Provincial Geriatric Hospital, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.
He S; Jiangxi Medical College, Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China.; Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.; Jiangxi Provincial Geriatric Hospital, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.
Kuang M; Jiangxi Medical College, Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China.; Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.; Jiangxi Provincial Geriatric Hospital, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.
Wang C; Jiangxi Medical College, Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China.; Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.; Jiangxi Provincial Geriatric Hospital, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.
Huang X; Jiangxi Medical College, Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China.; Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.; Jiangxi Provincial Geriatric Hospital, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China.
Sheng G; Jiangxi Provincial Geriatric Hospital, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China. .
Zou Y; Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi, China. .
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2024 Feb 18; Vol. 24 (1), pp. 22. Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/etiology
Male ; Humans ; Female ; Overweight/epidemiology ; Overweight/complications ; Retrospective Studies ; Obesity/complications ; Obesity/epidemiology ; Body Mass Index ; Waist Circumference
Czasopismo naukowe
Tytuł:
Evaluating the coding accuracy of type 2 diabetes mellitus among patients with non-alcoholic fatty liver disease.
Autorzy:
Lee S; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4Z6, Canada. .; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. .; Alberta Health Services, Calgary, AB, Canada. .; Data Intelligence for Health Lab, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. .
Shaheen AA; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4Z6, Canada.; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Campbell DJT; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4Z6, Canada.; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Department of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Naugler C; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4Z6, Canada.; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Jiang J; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Alberta Health Services, Calgary, AB, Canada.
Walker RL; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4Z6, Canada.; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Quan H; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4Z6, Canada.; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Lee J; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4Z6, Canada.; Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Data Intelligence for Health Lab, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Department of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2024 Feb 16; Vol. 24 (1), pp. 218. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/epidemiology
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Humans ; Comorbidity ; Patient Discharge ; Alberta/epidemiology
Czasopismo naukowe
Tytuł:
Development of a prediction model for predicting the prevalence of nonalcoholic fatty liver disease in Chinese nurses: the first-year follow data of a web-based ambispective cohort study.
Autorzy:
Che Y; Medical Examination Center, Peking university third hospital, Huayuan North Road No.49, Haidian District, Beijing, China.
Tang R; Nursing Department, Peking University Third Hospital, Huayuan North Road No.49, Haidian District, Beijing, China.
Zhang H; Department of Rehabilitation Medicine, Peking University Third Hospital, Huayuan North Road No.49, Haidian District, Beijing, China.
Yang M; Nursing Department, Peking University Third Hospital, Huayuan North Road No.49, Haidian District, Beijing, China.
Geng R; Nursing Department, Peking University Third Hospital, Huayuan North Road No.49, Haidian District, Beijing, China.
Zhuo L; Center for Clinical Epidemiology Research, Peking University Third Hospital, Huayuan North Road No.49, Haidian District, Beijing, China.
Wang P; Medical Examination Center, Peking university third hospital, Huayuan North Road No.49, Haidian District, Beijing, China.
Hu X; School of Nursing, Peking university, Xueyuan Road No. 38, Haidian District, Beijing, China.
Zhou Y; General surgery department, Peking university third hospital, Huayuan North Road No.49, Haidian District, Beijing, China.
Wang P; Oncology Radiotherapy Department, Peking university third hospital, Huayuan North Road No.49, Haidian District, Beijing, China.
Zhan S; Center for Clinical Epidemiology Research, Peking University Third Hospital, Huayuan North Road No.49, Haidian District, Beijing, China. .
Li B; Nursing Department, Peking University Third Hospital, Huayuan North Road No.49, Haidian District, Beijing, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Feb 14; Vol. 24 (1), pp. 72. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/diagnosis
Humans ; Female ; Cohort Studies ; Prevalence ; Risk Factors ; Internet ; China/epidemiology
Czasopismo naukowe
Tytuł:
Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease.
Autorzy:
Korkida F; Laboratory of Biology, School of Medicine, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
Stamatopoulou A; Laboratory of Biology, School of Medicine, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
Roubelakis MG; Laboratory of Biology, School of Medicine, National and Kapodistrian University of Athens (NKUA), Athens, Greece.; Cell and Gene Therapy Laboratory, Centre of Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.
Pokaż więcej
Źródło:
Stem cells translational medicine [Stem Cells Transl Med] 2024 Feb 14; Vol. 13 (2), pp. 107-115.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/therapy
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/pathology
Liver Diseases, Alcoholic*/complications
Liver Diseases, Alcoholic*/pathology
Liver Diseases, Alcoholic*/therapy
Mesenchymal Stem Cells*/pathology
Humans ; Liver/pathology ; Liver Cirrhosis/pathology
Czasopismo naukowe
Tytuł:
Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.
Autorzy:
Zheng K; Center of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yin Y; Sixth Clinical Medical School, Capital Medical University, Beijing, China.
Guo H; Department of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma L; Center of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu R; Center of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhao T; Center of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wei Y; Center of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhao Z; Department of Cardiovascular Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Cheng W; Center of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Feb 09; Vol. 15, pp. 1340644. Date of Electronic Publication: 2024 Feb 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Female ; Humans ; Male ; Asian People ; China/epidemiology ; Incidence ; Prospective Studies ; Health Status Indicators
Czasopismo naukowe
Tytuł:
Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery.
Autorzy:
Ayres ABS; Dept. of Surgery-School of Medical Sciences-State University of Campinas (UNICAMP), Rua Alexander Fleming, s/no, Campinas, (SP), Brazil.
Carneiro CRG; Dept. of Surgery-School of Medical Sciences-State University of Campinas (UNICAMP), Rua Alexander Fleming, s/no, Campinas, (SP), Brazil.
Gestic MA; Dept. of Surgery-School of Medical Sciences-State University of Campinas (UNICAMP), Rua Alexander Fleming, s/no, Campinas, (SP), Brazil.
Utrini MP; Dept. of Surgery-School of Medical Sciences-State University of Campinas (UNICAMP), Rua Alexander Fleming, s/no, Campinas, (SP), Brazil.
Chaim FDM; Dept. of Surgery-School of Medical Sciences-State University of Campinas (UNICAMP), Rua Alexander Fleming, s/no, Campinas, (SP), Brazil.
Callejas-Neto F; Dept. of Surgery-School of Medical Sciences-State University of Campinas (UNICAMP), Rua Alexander Fleming, s/no, Campinas, (SP), Brazil.
Chaim EA; Dept. of Surgery-School of Medical Sciences-State University of Campinas (UNICAMP), Rua Alexander Fleming, s/no, Campinas, (SP), Brazil.
Cazzo E; Dept. of Surgery-School of Medical Sciences-State University of Campinas (UNICAMP), Rua Alexander Fleming, s/no, Campinas, (SP), Brazil. .; Cidade Universitária Zeferino Vaz, Campinas, (SP), CEP 13085-000, Brazil. .
Pokaż więcej
Źródło:
Obesity surgery [Obes Surg] 2024 Feb; Vol. 34 (2), pp. 456-466. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/complications
Obesity, Morbid*/surgery
Bariatric Surgery*
Humans ; Female ; Adult ; Middle Aged ; Male ; Cross-Sectional Studies ; Ferritins ; Glucose ; Liver/pathology ; Biopsy
Czasopismo naukowe
Tytuł:
Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid.
Autorzy:
Lau HC; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Zhang X; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Ji F; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Lin Y; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Liang W; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Li Q; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Chen D; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Fong W; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Kang X; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Liu W; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Chu ES; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Ng QW; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Yu J; State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: .
Pokaż więcej
Źródło:
EBioMedicine [EBioMedicine] 2024 Feb; Vol. 100, pp. 104952. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/etiology
Non-alcoholic Fatty Liver Disease*/etiology
Non-alcoholic Fatty Liver Disease*/complications
Liver Neoplasms*/drug therapy
Liver Neoplasms*/etiology
Probiotics*/pharmacology
Probiotics*/therapeutic use
Pentanoic Acids*
Humans ; Animals ; Mice ; Lactobacillus acidophilus ; Liver/metabolism ; Cell Transformation, Neoplastic/metabolism ; Carcinogenesis/pathology ; Diet, High-Fat ; Choline/metabolism ; Mice, Inbred C57BL
Czasopismo naukowe
Tytuł:
Association between updated cardiovascular health construct and risks of non-alcoholic fatty liver disease.
Autorzy:
Huang J; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xin Z; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cao Q; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
He R; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hou T; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ding Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lu J; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang T; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhao Z; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang W; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ning G; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu M; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang L; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: .
Li M; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: .
Bi Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: .
Pokaż więcej
Źródło:
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2024 Feb; Vol. 34 (2), pp. 317-325. Date of Electronic Publication: 2023 Sep 24.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/epidemiology
Cardiovascular System*
Adult ; Humans ; Prospective Studies ; Blood Pressure ; Algorithms
Czasopismo naukowe
Tytuł:
Endotoxin biomarkers, hepatic fat fraction, liver volume and liver stiffness among adolescents at high-risk for non-alcoholic fatty liver disease: The HEROES study.
Autorzy:
Perng W; Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Salmon K; Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Schenker R; Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
Janssen RC; Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Friedman JE; Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Goran MI; Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Pediatric obesity [Pediatr Obes] 2024 Feb; Vol. 19 (2), pp. e13091. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/metabolism
Adolescent ; Humans ; Endotoxins/metabolism ; Pilot Projects ; Liver/diagnostic imaging ; Liver/metabolism ; Biomarkers/metabolism
Czasopismo naukowe
Tytuł:
The impact of bariatric surgery on liver enzymes in people with obesity: A 5-year observational study.
Autorzy:
Elhelw O; School of Medical Sciences, The University of Manchester, Manchester, UK.
Ragavan S; School of Medical Sciences, The University of Manchester, Manchester, UK.
Majeed W; Diabetes, Endocrinology and Obesity Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Alkhaffaf B; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Oesophago-Gastric and Bariatric Surgery, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Mohammed N; Gastroenterology, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Senapati S; Oesophago-Gastric and Bariatric Surgery, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK; University of Salford, Salford, UK.
Ammori BJ; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Oesophago-Gastric and Bariatric Surgery, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK; Bariatric, General, Gastrointestinal and Hepatobiliary Surgery, Burjeel Hospital, Abu Dhabi, United Arab Emirates.
Robinson JA; Gastroenterology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Syed AA; Diabetes, Endocrinology and Obesity Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: .
Pokaż więcej
Źródło:
The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland [Surgeon] 2024 Feb; Vol. 22 (1), pp. e26-e33. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/surgery
Non-alcoholic Fatty Liver Disease*/epidemiology
Bariatric Surgery*/methods
Obesity, Morbid*/complications
Obesity, Morbid*/surgery
Humans ; Retrospective Studies ; Glycated Hemoglobin ; Longitudinal Studies ; Alanine Transaminase ; Gastrectomy/methods ; Weight Loss/physiology ; Cholesterol ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies